Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
HC Wainwright & Co. analyst Edward White reiterates Curis (NASDAQ:CRIS) with a Buy and maintains $26 price target.
Curis (NASDAQ:CRIS) reported quarterly losses of $(2.03) per share which missed the analyst consensus estimate of $(1.67) by 21...
Truist Securities analyst Robyn Karnauskas maintains Curis (NASDAQ:CRIS) with a Buy and maintains $26 price target.
HC Wainwright & Co. analyst Edward White reiterates Curis (NASDAQ:CRIS) with a Buy and maintains $26 price target.
Cantor Fitzgerald analyst Li Watsek reiterates Curis (NASDAQ:CRIS) with a Overweight.
Data update expands AML dataset from 5 to 30 patientsLEXINGTON, Mass., May 14, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ:CRIS), ...
HC Wainwright & Co. analyst Edward White reiterates Curis (NASDAQ:CRIS) with a Buy and maintains $26 price target.
Curis (NASDAQ:CRIS) reported quarterly losses of $(2.05) per share which beat the analyst consensus estimate of $(2.12) by 3.3 ...
